Skip to main content

New discovery shows human cells can write RNA sequences into DNA

 

Date:
June 25, 2021
Source:
Thomas Jefferson University
Summary:
In a discovery that challenges long-held dogma in biology, researchers show that mammalian cells can convert RNA sequences back into DNA, a feat more common in viruses than eukaryotic cells.

Cells contain machinery that duplicates DNA into a new set that goes into a newly formed cell. That same class of machines, called polymerases, also build RNA messages, which are like notes copied from the central DNA repository of recipes, so they can be read more efficiently into proteins. But polymerases were thought to only work in one direction DNA into DNA or RNA. This prevents RNA messages from being rewritten back into the master recipe book of genomic DNA. Now, Thomas Jefferson University researchers provide the first evidence that RNA segments can be written back into DNA, which potentially challenges the central dogma in biology and could have wide implications affecting many fields of biology.

This work opens the door to many other studies that will help us understand the significance of having a mechanism for converting RNA messages into DNA in our own cells," says Richard Pomerantz, PhD, associate professor of biochemistry and molecular biology at Thomas Jefferson University. "The reality that a human polymerase can do this with high efficiency, raises many questions." For example, this finding suggests that RNA messages can be used as templates for repairing or re-writing genomic DNA.

The work was published June 11th in the journal Science Advances.

Together with first author Gurushankar Chandramouly and other collaborators, Dr. Pomerantz's team started by investigating one very unusual polymerase, called polymerase theta. Of the 14 DNA polymerases in mammalian cells, only three do the bulk of the work of duplicating the entire genome to prepare for cell division. The remaining 11 are mostly involved in detecting and making repairs when there's a break or error in the DNA strands. Polymerase theta repairs DNA, but is very error-prone and makes many errors or mutations. The researchers therefore noticed that some of polymerase theta's "bad" qualities were ones it shared with another cellular machine, albeit one more common in viruses -- the reverse transcriptase. Like Pol theta, HIV reverse transcriptase acts as a DNA polymerase, but can also bind RNA and read RNA back into a DNA strand.

In a series of elegant experiments, the researchers tested polymerase theta against the reverse transcriptase from HIV, which is one of the best studied of its kind. They showed that polymerase theta was capable of converting RNA messages into DNA, which it did as well as HIV reverse transcriptase, and that it actually did a better job than when duplicating DNA to DNA. Polymerase theta was more efficient and introduced fewer errors when using an RNA template to write new DNA messages, than when duplicating DNA into DNA, suggesting that this function could be its primary purpose in the cell.

The group collaborated with Dr. Xiaojiang S. Chen's lab at USC and used x-ray crystallography to define the structure and found that this molecule was able to change shape in order to accommodate the more bulky RNA molecule -- a feat unique among polymerases.

"Our research suggests that polymerase theta's main function is to act as a reverse transcriptase," says Dr. Pomerantz. "In healthy cells, the purpose of this molecule may be toward RNA-mediated DNA repair. In unhealthy cells, such as cancer cells, polymerase theta is highly expressed and promotes cancer cell growth and drug resistance. It will be exciting to further understand how polymerase theta's activity on RNA contributes to DNA repair and cancer-cell proliferation."

Comments

Popular posts from this blog

From A Lawyer To A Vampire Woman In Mexico

Hope Apr 23, 2020 Maria Jose Cristerna's tattooed skin, body piercings and transformations make her look stunning, even to a person familiar with extreme body modifications. She is famous and a regular on television shows and events. The simplest thing that might involve going out, like taking out the garbage or going to the farmer’s market, can become quite an ordeal. She never goes anywhere unnoticed; people ask her continuously if she really is the “Vampire Woman”. She becomes the center of attention be it in a supermarket or in a concert. She seldom picks up her kids from school herself because she is immediately accosted by crowds of parents and students. She tells me with a big laugh that her “friends and family jokingly refuse to go to the movies with her because people will come up non-stop asking for autographs or to have their picture taken with her and there is no way to enjoy a movie like that….” She is kind and very patient with everybody but she prefers the int...

Minister of Health reveals drug used to treat COVID19 patients in Nigeria

Dr Osagie Ehanire, Nigeria's Minister of Health, has disclosed the drug used to treat COVID-19 patients in Nigeria. Addressing members of the House of Representatives today Tuesday May 5, Ehanire said Remdesivir is being used to treat patients with the virus. “We have been using that (Remdesivir); we have tried that in Lagos too. So, we have tried the antiretroviral drug to see what effect it has” he said The Minister said the drug which was originally developed as a potential treatment for Ebola, is one of the options which Nigeria has adopted for in treating COVID-19 patients. Remdesivir was tested in 1,063 hospitalized Coronavirus patients around the world and has proven to reduce the time it takes patients to recover by 31%. 11 days on average versus 15 days for those just given usual care.

French football stares at financial black hole with broadcasters set to hold back payments

French football stares at financial black hole with broadcasters set to hold back payments YESTERDAY AT 6:36 PM | AFP Tell your friends       The financial crisis facing football as a result of the coronavirus pandemic has been laid bare in France, where a decision to withhold payments due as part of a broadcast deal for Ligue 1 matches is set to leave clubs reeling. AFP French Ligue 1 clubs are set to miss out on 110 million euros if leading broadcaster Canal Plus holds back money that was due to be paid this week Canal Plus, the pay TV giant and long-time broadcaster of France's top flight, stated its intention to hold back a scheduled 110 million-euro ($121 million) payment in a letter to the French league revealed by the country's leading sports daily, L'Equipe. The money is in theory due this weekend and is the equivalent of 15 percent of the total broadcast money for the season in Ligue 1. "In case of force majeure, when matches are ...